These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28781782)

  • 1.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Mol Clin Oncol; 2017 Aug; 7(2):183-187. PubMed ID: 28781782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Features of Ductal Carcinoma
    Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Kuwano H
    Anticancer Res; 2017 Sep; 37(9):5053-5056. PubMed ID: 28870933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
    Sarikaya I; Sarikaya A; Albatineh AN; Tastekin E; Sezer YA
    Asia Ocean J Nucl Med Biol; 2020; 8(1):27-35. PubMed ID: 32064280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study.
    Fujioka T; Kubota K; Toriihara A; Machida Y; Okazawa K; Nakagawa T; Saida Y; Tateishi U
    World J Radiol; 2016 Aug; 8(8):743-9. PubMed ID: 27648168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
    Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
    J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
    Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
    Doyle B; Al-Mudhaffer M; Kennedy MM; O'Doherty A; Flanagan F; McDermott EW; Kerin MJ; Hill AD; Quinn CM
    J Clin Pathol; 2009 Jun; 62(6):534-8. PubMed ID: 19190009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
    Shigematsu H; Kadoya T; Masumoto N; Matsuura K; Emi A; Kajitani K; Amioka A; Okada M
    Clin Breast Cancer; 2014 Oct; 14(5):358-64. PubMed ID: 24962555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management.
    Sato Y; Kinoshita T; Suzuki J; Jimbo K; Asaga S; Hojo T; Yoshida M; Tsuda H
    Breast Cancer; 2016 Sep; 23(5):761-70. PubMed ID: 26324092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ.
    Al-Ameer AY; Al Nefaie S; Al Johani B; Anwar I; Al Tweigeri T; Tulbah A; Alshabanah M; Al Malik O
    World J Clin Oncol; 2016 Apr; 7(2):258-64. PubMed ID: 27081649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factors.
    Seo YY; Yoo IR; Park SY; Oh JK; Kim SH; Sohn HS
    Breast Cancer; 2017 May; 24(3):353-361. PubMed ID: 27312540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
    Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.
    Doebar SC; de Monyé C; Stoop H; Rothbarth J; Willemsen SP; van Deurzen CH
    Breast; 2016 Jun; 27():15-21. PubMed ID: 27212695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ.
    Yoon HJ; Kim Y; Kim BS
    Eur Radiol; 2015 Dec; 25(12):3648-58. PubMed ID: 26063655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of low grade ductal carcinoma in situ of the breast with difficulties in making the preoperative diagnosis after detection by FDG-PET].
    Tsurudome Y; Katsuki T; Konishi T; Nagata J; Inoue Y; Nagata T; Shibao K; Higure A; Hirata K; Nakayama Y; Okamoto K; Nagata N; Yamaguchi K
    J UOEH; 2008 Sep; 30(3):321-8. PubMed ID: 18783013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
    Prendeville S; Ryan C; Feeley L; O'Connell F; Browne TJ; O'Sullivan MJ; Bennett MW
    Breast; 2015 Jun; 24(3):197-200. PubMed ID: 25681861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.